Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss Of Lung Tissue In Patients With Deficiency-related Emphysema
Links shared publicly online about this topic.
- 723total visits
Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss Of Lung Tissue In Patients With Deficiency-related Emphysema
Talecris Biotherapeutics (Nasdaq: TLCR) announced the publication of combined data from two studies demonstrating that augmentation therapy with Alpha(1)-Proteinase Inhibitor (Human) (A1PI) signif
View full resource at medicalnewstoday.com
Tags: Lung, COPD, Cystic Fibrosis, Pharma, Phase 2 Clinical Trial, Children's Health, Emphysema
Most Recently Shared on November 16, 2010 at 9:05 pm By:
Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss Of Lung Tissue In Patients W... http://mnt.to/3MDy
Also Shared By:
Advertisement
MNT Pharma News
@mnt_pharma
Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss Of Lung Tissue In Patients W... http://mnt.to/3MDy
1 year ago...